Terms: = Prostate cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Staging
4 results:
1. Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI.
Laudicella R; Rüschoff JH; Ferraro DA; Brada MD; Hausmann D; Mebert I; Maurer A; Hermanns T; Eberli D; Rupp NJ; Burger IA
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3917-3928. PubMed ID: 35435496
[TBL] [Abstract] [Full Text] [Related]
2. Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer.
Valentin B; Schimmöller L; Ullrich T; Klingebiel M; Demetrescu D; Sawicki LM; Lakes J; Mally D; Quentin M; Esposito I; Albers P; Antoch G; Arsov C
Abdom Radiol (NY); 2021 Jun; 46(6):2751-2759. PubMed ID: 33452898
[TBL] [Abstract] [Full Text] [Related]
3. Identifying Cases of Metastatic prostate cancer Using Machine Learning on Electronic Health Records.
Seneviratne MG; Banda JM; Brooks JD; Shah NH; Hernandez-Boussard TM
AMIA Annu Symp Proc; 2018; 2018():1498-1504. PubMed ID: 30815195
[TBL] [Abstract] [Full Text] [Related]
4. Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer?
Levran Z; Gonzalez JA; Diokno AC; Jafri SZ; Steinert BW
Br J Urol; 1995 Jun; 75(6):778-81. PubMed ID: 7542138
[TBL] [Abstract] [Full Text] [Related]
